Comparison of intermediate and high dose valaciclovir for the prophylaxis of CMV viraemia in allogeneic stem cell transplant recipients
Not Applicable
Completed
- Conditions
- Infections and Infestations: Cytomegalovirus (CMV) infectionInfections and InfestationsCytomegalovirus disease
- Registration Number
- ISRCTN78766104
- Lead Sponsor
- Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 110
Inclusion Criteria
110 patients, 55 in each treatment arm.
Exclusion Criteria
Does not match inclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method